Where Will Axsome Therapeutics Be in 2030 as Auvelity Expands Into Alzheimer's?
Auvelity's Alzheimer's expansion could transform Axsome by 2030.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Rental Cars Shouldn’t Face Another Layer of Tax
Imposing sales taxes on rental car companies’ fleet purchases, in addition to the sales and rental car excise taxes levied when those cars are rented, yields double taxation and causes harmful tax…
Tom Lee sees $2 trillion wealth transfer fueling crypto demand as Bitmine buys more ether
The Bitmine chairman said he expects younger investors to drive demand for digital assets as his ether treasury company inches closer to owning 5% of the total supply.
Ukraine, Saudi Strikes and Soaring Oil Risks
Tina Fordham, founder of Fordham Global Foresight joined Bloomberg Open Interest to break down President Trump’s surprise diesel deal with Russia, Zelensky’s demand for an energy ceasefire, and fresh…
How B2B Invoices Became Payment Infrastructure
Two years ago, a B2B invoice was largely a record of a transaction already agreed upon, passed between finance departments to trigger payment, reconciliation and collections.
Why Micron Stock Dropped on Monday
CXMT plans a new DRAM product targeting the AI market before end of 2026.